CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Ionis Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 14, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Antisense DesignROCHE INNOVATION CENTER COPENHAGENNov 12, 2020

Explore Ionis Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 17, 2024Modulation Of Ube3A-Ats Expression3
Aug 23, 2023Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations1
Dec 14, 2022Methods For Modulating C9Orf72 Expression2
Jul 1, 2020Modulation Of Ube3A-Ats Expression1
Jun 10, 2020Linkage Modified Gapped Oligomeric Compounds And Uses Thereof1
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
Aug 21, 2019Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression1
Aug 14, 2019Selective Reduction Of Allelic Variants1
Mar 27, 2019Selective Reduction Of Allelic Variants1
Dec 26, 2018Modulation Of Alpha Synuclein Expression1

Top competitors of Ionis Pharmaceuticals

Top competitors of Ionis Pharmaceuticals based on patent oppositions.